Global Radioimmunotherapy Competitive Landscape Professional Research Report 2024

Research Summary

Radioimmunotherapy (RIT) is a specialized cancer treatment that harnesses the specificity of monoclonal antibodies and the cytotoxic power of radiation. It involves attaching radioactive isotopes to monoclonal antibodies, which are proteins designed to selectively target antigens found on cancer cells. Once administered into the patient's bloodstream, these antibodies seek out and bind to the cancer cells, delivering radiation directly to the tumor sites. The emitted radiation damages the cancer cells' DNA, leading to their destruction or death. Radioimmunotherapy offers the advantage of precise targeting, minimizing harm to surrounding healthy tissues compared to traditional radiation therapy and chemotherapy. It is particularly effective against certain types of blood cancers like lymphoma and leukemia, and ongoing research aims to expand its application to other types of solid tumors, offering promising therapeutic options for cancer patients.

According to DIResearch's in-depth investigation and research, the global Radioimmunotherapy market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Radioimmunotherapy include Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Radioimmunotherapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Radioimmunotherapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Radioimmunotherapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radioimmunotherapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Radioimmunotherapy Include:

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

Curium Pharmaceuticals

Gilead Sciences

Clarity Pharmaceuticals

Curasight

Nordic Nanovector

Philogen

RadioMedix

Telix Pharmaceuticals

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

Radioimmunotherapy Product Segment Include:

Beta-emitting

Targeted Alpha Therapy

Radioimmunotherapy Product Application Include:

Solid Tumor

Non Hodgkin Lymphoma

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Radioimmunotherapy Industry PESTEL Analysis

Chapter 3: Global Radioimmunotherapy Industry Porter's Five Forces Analysis

Chapter 4: Global Radioimmunotherapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Radioimmunotherapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Radioimmunotherapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Radioimmunotherapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Radioimmunotherapy Market Overview

1.1 Product Definition and Statistical Scope

1.2 Radioimmunotherapy Product by Type

1.2.1 Global Radioimmunotherapy Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Beta-emitting

1.2.3 Targeted Alpha Therapy

1.3 Radioimmunotherapy Product by Application

1.3.1 Global Radioimmunotherapy Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Solid Tumor

1.3.3 Non Hodgkin Lymphoma

1.4 Global Radioimmunotherapy Market Revenue Analysis (2019-2030)

1.5 Radioimmunotherapy Market Development Status and Trends

1.5.1 Radioimmunotherapy Industry Development Status Analysis

1.5.2 Radioimmunotherapy Industry Development Trends Analysis

2 Radioimmunotherapy Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Radioimmunotherapy Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Radioimmunotherapy Market Analysis by Regions

4.1 Radioimmunotherapy Overall Market: 2023 VS 2024 VS 2030

4.2 Global Radioimmunotherapy Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Radioimmunotherapy Revenue and Market Share by Region (2019-2024)

4.2.2 Global Radioimmunotherapy Revenue Forecast by Region (2025-2030)

5 Global Radioimmunotherapy Market Size by Type and Application

5.1 Global Radioimmunotherapy Market Size by Type

5.2 Global Radioimmunotherapy Market Size by Application

6 North America

6.1 North America Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Radioimmunotherapy Market Size by Type

6.4 North America Radioimmunotherapy Market Size by Application

6.5 North America Radioimmunotherapy Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Radioimmunotherapy Market Size by Type

7.4 Europe Radioimmunotherapy Market Size by Application

7.5 Europe Radioimmunotherapy Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Radioimmunotherapy Market Size by Type

8.4 China Radioimmunotherapy Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Radioimmunotherapy Market Size by Type

9.4 APAC (excl. China) Radioimmunotherapy Market Size by Application

9.5 APAC (excl. China) Radioimmunotherapy Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Radioimmunotherapy Market Size by Type

10.4 Latin America Radioimmunotherapy Market Size by Application

10.5 Latin America Radioimmunotherapy Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Radioimmunotherapy Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Radioimmunotherapy Market Size by Type

11.4 Middle East & Africa Radioimmunotherapy Market Size by Application

11.5 Middle East & Africa Radioimmunotherapy Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Radioimmunotherapy Market Revenue by Key Manufacturers (2020-2024)

12.2 Radioimmunotherapy Competitive Landscape Analysis and Market Dynamic

12.2.1 Radioimmunotherapy Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bayer

13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bayer Radioimmunotherapy Product Portfolio

13.1.3 Bayer Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Novartis

13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Novartis Radioimmunotherapy Product Portfolio

13.2.3 Novartis Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Lantheus

13.3.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Lantheus Radioimmunotherapy Product Portfolio

13.3.3 Lantheus Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Aurobindo Pharma

13.4.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Aurobindo Pharma Radioimmunotherapy Product Portfolio

13.4.3 Aurobindo Pharma Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Mundipharma

13.5.1 Mundipharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Mundipharma Radioimmunotherapy Product Portfolio

13.5.3 Mundipharma Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 China Isotope & Radiation

13.6.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 China Isotope & Radiation Radioimmunotherapy Product Portfolio

13.6.3 China Isotope & Radiation Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Curium Pharmaceuticals

13.7.1 Curium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Curium Pharmaceuticals Radioimmunotherapy Product Portfolio

13.7.3 Curium Pharmaceuticals Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Gilead Sciences

13.8.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Gilead Sciences Radioimmunotherapy Product Portfolio

13.8.3 Gilead Sciences Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Clarity Pharmaceuticals

13.9.1 Clarity Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Clarity Pharmaceuticals Radioimmunotherapy Product Portfolio

13.9.3 Clarity Pharmaceuticals Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Curasight

13.10.1 Curasight Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Curasight Radioimmunotherapy Product Portfolio

13.10.3 Curasight Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Nordic Nanovector

13.11.1 Nordic Nanovector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Nordic Nanovector Radioimmunotherapy Product Portfolio

13.11.3 Nordic Nanovector Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Philogen

13.12.1 Philogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Philogen Radioimmunotherapy Product Portfolio

13.12.3 Philogen Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 RadioMedix

13.13.1 RadioMedix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 RadioMedix Radioimmunotherapy Product Portfolio

13.13.3 RadioMedix Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Telix Pharmaceuticals

13.14.1 Telix Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Telix Pharmaceuticals Radioimmunotherapy Product Portfolio

13.14.3 Telix Pharmaceuticals Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Orano Med

13.15.1 Orano Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Orano Med Radioimmunotherapy Product Portfolio

13.15.3 Orano Med Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Actinium Pharmaceuticals

13.16.1 Actinium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Actinium Pharmaceuticals Radioimmunotherapy Product Portfolio

13.16.3 Actinium Pharmaceuticals Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Y-mAbs Therapeutics

13.17.1 Y-mAbs Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Y-mAbs Therapeutics Radioimmunotherapy Product Portfolio

13.17.3 Y-mAbs Therapeutics Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Fusion Pharmaceuticals

13.18.1 Fusion Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Fusion Pharmaceuticals Radioimmunotherapy Product Portfolio

13.18.3 Fusion Pharmaceuticals Radioimmunotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Radioimmunotherapy Industry Chain Analysis

14.2 Radioimmunotherapy Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Radioimmunotherapy Typical Downstream Customers

14.4 Radioimmunotherapy Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support